Navigation Links
New Research Reveals Unforeseen Side Effect of the Breast Cancer Movement
Date:12/12/2008

PHILADELPHIA and SAN ANTONIO, Texas, Dec. 12 /PRNewswire-USNewswire/ -- A groundbreaking study developed by Breastcancer.org reports that American girls are significantly affected by the steady stream of information and messaging around breast cancer. This study surveyed over 2,400 girls ages 8-18. Some of the key findings from this research revealed that nearly 30% of the girls surveyed believed that a normal sign of breast development was a symptom of breast cancer, and more than 20% of girls believed that infection, tanning, drug use and stress could cause cancer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080624/NYTU050LOGO-b)

"The research findings really speak to the fact that breast cancer is ever-present in our girls' lives," said Dr. Marisa Weiss, President and Founder of Breastcancer.org. "Our study found that nearly 75% of these girls have someone in their lives with breast cancer ... and that they are clearly affected by breast cancer messaging in their daily lives."

"The breast cancer advocacy movement has improved countless lives-and saved so many. It's been truly revolutionary and it must continue. However, in balance, we need to inform and positively frame this information for our girls in an age appropriate and relevant manner," said Dr. Weiss.

In response to this study, Breastcancer.org has developed the Prevention Initiative for girls, a national outreach program that arms girls and young women with the facts and tools designed to promote breast health and reduce their risk of getting breast cancer during their lifetime.

Dr. Weiss will announce the study results at a poster presentation on December 13, 2008, at the CTRC-AACR San Antonio Breast Cancer Symposium. Other authors include Dr. Jennifer Griggs (University of Michigan); Dr. Larry Norton (Memori
'/>"/>

SOURCE Breastcancer.org
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Md., Dec. 4 Northwest B...C Bulletin Board: NWBO) announced today that the U...nt application on a system for automation of the i...DCVax® therapeutic cancer vaccines. These in...h concentration of dendritic cells (which are the ...
(Date:12/3/2009)...RK, Dec. 3 Guidepoint Global, LLC...d the launch of their Sleep Apnea Tracker, a month...jects trends and market share in the worldwide Sle...ptures actual patient usage for 87 different Sleep...15 different equipment providers going back to Jan...
(Date:12/3/2009)..., N.J., Dec. 3 A genetic...eveloping a potentially life-threatening blood dis...es or chemicals is one of several medical discover...Diagnostics (NYSE: DGX ) will present during the...Meeting and Exposition, December 5-8, 2009, in New...
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Tiny Batteries Can Cause Big Problems for Young Children 58870 1Tiny Batteries Can Cause Big Problems for Young Children 58870 28 Ounces a Day of POM Wonderful 100 25 Pomegranate Juice May Slow Progression of Carotid Intima Media Thickness 28CIMT 29 in Patients with Elevated C 58866 18 Ounces a Day of POM Wonderful 100 25 Pomegranate Juice May Slow Progression of Carotid Intima Media Thickness 28CIMT 29 in Patients with Elevated C 58866 28 Ounces a Day of POM Wonderful 100 25 Pomegranate Juice May Slow Progression of Carotid Intima Media Thickness 28CIMT 29 in Patients with Elevated C 58866 3American HealthTech and Vocollect Healthcare Systems Announce an Alliance to Deliver Unified Electronic Medical Records 58862 1American HealthTech and Vocollect Healthcare Systems Announce an Alliance to Deliver Unified Electronic Medical Records 58862 2American HealthTech and Vocollect Healthcare Systems Announce an Alliance to Deliver Unified Electronic Medical Records 58862 3
...ls that multiply and migrate in the, embryo to giv... a finding, that suggests that these cells might ...n., Oct. 3 Investigators at St.,Jude Children,s R...he,origin of the mammalian lymphatic vasculature -...to various essential housekeeping functions in the...
...maceuticals, Inc. (Nasdaq: TPPH ) announced today...i-center study of TPI 287 in patients with,advance...ial exploring the,activity of TPI 287 in various t...this year in advanced hormone refractory prostate ...oved for pancreatic cancer and,effective treatment...
Other Medicine Technology:St. Jude Settles Century-Old Debate on Origin of Mammalian Network of Lymphatic Vessels 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 3Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 4Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 5
(Date:12/4/2009)... water and fruit consumption leads to success, st...y News) -- Increased exercise, reduced soda consum...ve weight control strategies for adolescents, a ne...scents about their weight-control strategies and l... weight and 68 had not. The responses were grouped...
(Date:12/4/2009)...ec. 4 Substantial progress has bee...mmunity,s ability to diagnose and treat epilepsy a...sy management has not reached most of the 50 milli...nearly three million people in the United States w... Schachter, M.D., president of the American Epilep...
(Date:12/4/2009)...lance urged for at-risk patient groups , ...od cancers, particularly Ewing sarcomas and centra...currence, U.S. researchers have found. , The st...rvivors of the most common pediatric cancers who w...y. , The researchers found that the overall can...
(Date:12/4/2009)...erol-lowering drugs known as statins are among the...tudy by researchers at Fred Hutchinson Cancer Rese...m cell transplant patients from one of the most se...apy: graft-versus-host disease, or GVHD. The findi...e journal Blood . , In a retrospective study of ...
(Date:12/4/2009)... of risks, many hesitate to take breast cancer dru...hDay News) -- Worries about side effects are a maj...high risk for breast cancer are willing to take th...dy finds. , In an effort to inform women about ...t the University of Michigan Comprehensive Cancer ...
Breaking Medicine News(10 mins):Health News:Teens Lose More Weight Using Healthy Strategies 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2Health News:High-Risk Women May Often Avoid Using Tamoxifen 2
...wait Ministry of Health stockpiles thyroid-blockin...es , , MOORESVILLE, N.C., Jan. 22 Nukepills.com ...lion doses) of ThyroShield(TM) Potassium Iodide to...otecting its citizens during a nuclear radiation e...
...MILTON, Bermuda, Jan. 22 Warner Chilcott Limited ...ue its 2009 Financial Guidance after market close ...ng a press release, Roger Boissonneault, President... discuss the 2009 Financial Guidance for all inter...
... , , , , CARLSBAD, Cal...automated molecular testing solutions announced to... to demonstrate the value of genetic variants in d...artery disease, peripheral vascular disease and ce...
... Health Industry Professiona...ama , New York (PRWEB) Ja...published a brief entitled 10 Minutes on Health R...are coverage for the nation,s employers and the ...
... To encourage dental care i...edures, including the anesthesia, from January thr...od dental health, you may avoid some serious and e...g the health and well-being of your pets. The numb...
... recent survey by Medical College of Wisconsin res...ert Hospital Emergency Department revealed that Me...ell prepared for disasters as the rest of the coun...22, 2009. , The purpose of the survey was to ass...
Other Medicine News:Health News:Kuwait Purchases 5.4 Million Doses of Emergency Nuclear Radiation Drug from Nukepills.com 2Health News:AutoGenomics CYP 2C19 Test Used in Study to Personalize Clopidogrel (Plavix) Dosing in Patients 2Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 2Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 3Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 4Health News:Indian Head Animal Hospital Announces Dental Discounts for Pets through March 31st 2Health News:Personal disaster preparedness 2
Vascular ClearWay Irrigating PTFE Balloon Catheter
PureVision Contact Lenses
Arx™ Ceramic Spinal Spacer System™
QC 900 Hematocrit Control
Medicine Products: